Spokesperson Lin Jian reaffirmed that the Chinese mainland’s countermeasures to two rounds of U.S. tariffs targeting China on the pretext of fentanyl remain in effect.
At a regular press briefing on Wednesday, Lin said that the United States had "unreasonably imposed" 20 percent duties on Chinese goods after the Geneva talks, citing fentanyl issues. In response, Beijing swiftly introduced reciprocal measures to protect its legitimate rights and interests.
"These countermeasures remain effective," Lin stressed, noting that China continues to monitor the impact of U.S. duties on trade flows. The move highlights ongoing tensions between the world’s two largest economies over drug-control allegations and trade policy.
While details of the measures were announced earlier, industry observers say they include adjusted duties on select U.S. imports, which could ripple across global supply chains. Businesses and tech startups with cross-border operations may need to reassess sourcing and pricing strategies as tensions persist.
Trade watchers believe that maintaining these countermeasures sends a clear message that the Chinese mainland will not accept unilateral tariffs under the guise of non-commercial issues. It also underscores Beijing’s commitment to defending its economic interests on the world stage.
As U.S.-China relations navigate complex discussions—including recent Geneva negotiations on fentanyl control—both sides face pressure to balance domestic concerns with global economic stability. Young global citizens, entrepreneurs, and thought leaders alike will be watching how these moves shape future trade dynamics.
Reference(s):
China: Countermeasures for U.S. tariff citing fentanyl still effective
cgtn.com
